Stock Analysis on Net

Shockwave Medical Inc. (NASDAQ:SWAV)

$22.49

This company has been moved to the archive! The financial data has not been updated since May 6, 2024.

Common-Size Income Statement

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Shockwave Medical Inc., common-size consolidated income statement

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Product revenue
Revenue
Cost of product revenue
Cost of revenue
Gross profit
Research and development
Sales and marketing
General and administrative
Operating expenses
Income (loss) from operations
Loss from equity method investment
Interest expense
Change in fair value of warrant liability
Other income (expense), net
Net income (loss) before taxes
Income tax (provision) benefit
Net income (loss)

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Income statement item Description The company
Income (loss) from operations The net result for the period of deducting operating expenses from operating revenues. Shockwave Medical Inc. income (loss) from operations as a percentage of revenue increased from 2021 to 2022 but then slightly decreased from 2022 to 2023.
Net income (loss) before taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Shockwave Medical Inc. net income (loss) before taxes as a percentage of revenue increased from 2021 to 2022 but then slightly decreased from 2022 to 2023.
Net income (loss) The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Shockwave Medical Inc. net income (loss) as a percentage of revenue increased from 2021 to 2022 but then slightly decreased from 2022 to 2023.